380 related articles for article (PubMed ID: 3661679)
1. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
Till GO; Morganroth ML; Kunkel R; Ward PA
Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.
von Zabern I; Hinsch B; Przyklenk H; Schmidt G; Vogt W
Immunobiology; 1980 Dec; 157(4-5):499-514. PubMed ID: 6905795
[TBL] [Abstract][Full Text] [Related]
3. Systemic complement activation and acute lung injury.
Till GO; Ward PA
Fed Proc; 1986 Jan; 45(1):13-8. PubMed ID: 3940902
[TBL] [Abstract][Full Text] [Related]
4. Complement and neutrophil-mediated injury of perfused rat lungs.
Morganroth ML; Till GO; Kunkel RG; Ward PA
Lab Invest; 1986 May; 54(5):507-14. PubMed ID: 3702342
[TBL] [Abstract][Full Text] [Related]
5. Systemic complement activation, lung injury, and products of lipid peroxidation.
Ward PA; Till GO; Hatherill JR; Annesley TM; Kunkel RG
J Clin Invest; 1985 Aug; 76(2):517-27. PubMed ID: 4031060
[TBL] [Abstract][Full Text] [Related]
6. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.
Ward PA; Till GO; Kunkel R; Beauchamp C
J Clin Invest; 1983 Sep; 72(3):789-801. PubMed ID: 6886005
[TBL] [Abstract][Full Text] [Related]
7. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
Cheung AK; Parker CJ; Wilcox L
Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
[TBL] [Abstract][Full Text] [Related]
8. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.
Till GO; Johnson KJ; Kunkel R; Ward PA
J Clin Invest; 1982 May; 69(5):1126-35. PubMed ID: 7068850
[TBL] [Abstract][Full Text] [Related]
9. Functional role of the noncatalytic subunit of complement C5 convertase.
Rawal N; Pangburn MK
J Immunol; 2000 Feb; 164(3):1379-85. PubMed ID: 10640753
[TBL] [Abstract][Full Text] [Related]
10. Reduction of total hemolytic complement activity with Naja haje cobra venom factor does not prevent endotoxin-induced lung injury in sheep.
Flick MR; Horn JK; Hoeffel JM; Goldstein IM
Am Rev Respir Dis; 1986 Jan; 133(1):62-7. PubMed ID: 3510582
[TBL] [Abstract][Full Text] [Related]
11. Chain structure of cobra venom factor from Naja naja and Naja haje venom.
von Zabern I; Przyklenk H; Vogt W
Scand J Immunol; 1982 Apr; 15(4):357-62. PubMed ID: 7100817
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent.
Cardozo C; Edelman J; Jagirdar J; Lesser M
Am Rev Respir Dis; 1991 Jul; 144(1):173-8. PubMed ID: 2064126
[TBL] [Abstract][Full Text] [Related]
13. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment with Cobra venom factor alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats.
Mao YF; Yu QH; Zheng XF; Liu K; Liang WQ; Wang YW; Deng XM; Jiang L
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2207-17. PubMed ID: 23893188
[TBL] [Abstract][Full Text] [Related]
15. Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors.
Webster RO; Larsen GL; Mitchell BC; Goins AJ; Henson PM
Am Rev Respir Dis; 1982 Mar; 125(3):335-40. PubMed ID: 7065543
[TBL] [Abstract][Full Text] [Related]
16. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats.
Proctor LM; Strachan AJ; Woodruff TM; Mahadevan IB; Williams HM; Shiels IA; Taylor SM
Int Immunopharmacol; 2006 Aug; 6(8):1224-32. PubMed ID: 16782534
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.
Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM
J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730
[TBL] [Abstract][Full Text] [Related]
18. The role of complement in cigarette smoke-induced chemotactic activity of lung fluids.
Kew RR; Ghebrehiwet B; Janoff A
Am Rev Respir Dis; 1986 Mar; 133(3):478-81. PubMed ID: 3954255
[TBL] [Abstract][Full Text] [Related]
19. Requirements for L-selectin in neutrophil-mediated lung injury in rats.
Mulligan MS; Miyasaka M; Tamatani T; Jones ML; Ward PA
J Immunol; 1994 Jan; 152(2):832-40. PubMed ID: 7506737
[TBL] [Abstract][Full Text] [Related]
20. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje.
Van den Berg CW; Aerts PC; Van Dijk H
J Immunol Methods; 1991 Feb; 136(2):287-94. PubMed ID: 1999656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
